5 October 2026
ProBiotix Health plc
("ProBiotix" or the "Company")
Change of Auditor
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, announces the appointment of PKF Littlejohn LLP as the Company's new auditor, following the resignation of Gerald Edelman LLP.
Gerald Edelman LLP has confirmed that there are no matters connected with their ceasing to hold office that they consider should be brought to the attention of the members or creditors of the Company.
The Board would like to place on record its thanks to Gerald Edelman LLP for its services to the Company throughout their tenure of office.
For further information, please contact:
|
ProBiotix Health plc |
|
|
Steen Andersen, Chief Executive Officer Miles Nolan, Investor Relations |
|
|
AlbR Capital Limited Aquis Corporate Adviser and Broker |
Tel: 020 7469 0930 |
|
David Coffman Dan Harris |
Notes to Editors:
ProBiotix Health is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.
The Company has a unique approach; discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.